Model Details

Patient Information for Model: BCM-0132

Patient Information
Clinical Timeline

Color Keys:
 
 Positive
 
 Negative
 
 N/A

Clinical Information at Collection
Clinical Biomarkers/Mutations at Collection
Pathology Information at Collection

Model Information for Model: BCM-0132

Model Details - Initial Implantation of Patient Tissue
Biomarkers & Mutations
Model Details - Acceptable Conditions for Passaging
Mutations (Cancer Gene Census List)

The number of models in this collection with mutations in the listed gene;
may include models that are not publicly available for distribution.
The number of models in this collection with mutations at the listed site;
may include models that are not publicly available for distribution.
GeneChrStartEndRefAltcDNA ChangeCodon ChangeProtein ChangeTVAF Gene Mutation Freq. Site Mutation Freq.Most Severe EffectAll EffectsMutation ImpactTranscript IDClinVar Clinical SignificanceCOSMIC IDgnomAD Non-Cancer AFdbSNP IDGene Mutation Freq.Site Mutation Freq.Transcript IDClinVar Clinical SignificanceCOSMIC IDdbSNP ID
AFF4chr5132897083132897103GTGTAGCTATTCCCAGTGCCCGc.1527_1546delcaGGGCACTGGGAATAGCTACAct/cactp.Q509Hfs*20.52371Frameshift MutationFrameshift MutationHIGHENST00000265343.10



71ENST00000265343.10
ARchrX6754651467546517TGGCTc.1418_1420delGGC/-p.G473del0.858483In-frame DeletionIn-frame DeletionMODERATEENST00000374690.9

COSV65958513

483ENST00000374690.9COSV65958513
ARID1Achr12669676126696761CTc.358C>TCcg/Tcgp.P120S0.952192Missense VariantMissense VariantMODERATEENST00000324856.13
Conflicting_interpretations_of_pathogenicity
COSV61373973
0.000271628000rs571264557
192ENST00000324856.13Conflicting_interpretations_of_pathogenicityCOSV61373973rs571264557
ARID1Bchr6157206530157206534CTGTTCc.5763_5766delcTGTTt/ctp.F1921Lfs*520.937371Frameshift MutationFrameshift MutationHIGHENST00000636930.2

COSV99269679
rs1554237269
371ENST00000636930.2COSV99269679rs1554237269
BIRC6chr23252977132529771CTc.12041C>TaCa/aTap.T4014I1.0151Missense VariantMissense VariantMODERATEENST00000421745.6


0.000038112000rs141336419
151ENST00000421745.6rs141336419
BRCA2chr133234057532340575CAc.6220C>ACac/Aacp.H2074N0.985212Missense VariantMissense VariantMODERATEENST00000380152.7
Benign

0.000727523000rs34309943
212ENST00000380152.7Benignrs34309943
BUB1Bchr154019665640196656GCc.1170G>CgaG/gaCp.E390D0.98553Missense VariantMissense VariantMODERATEENST00000287598.11
Benign
COSV55010791
0.008655650000rs1017842
53ENST00000287598.11BenignCOSV55010791rs1017842
CIITAchr161090907010909070AGc.2702A>GcAg/cGgp.Q901R0.3868584Missense VariantMissense VariantMODERATEENST00000618327.4
Benign

0.983235000000rs7197779
8584ENST00000618327.4Benignrs7197779
CLTCL1chr221921997019219970CTc.2834G>AcGc/cAcp.R945H0.444193Missense VariantMissense VariantMODERATEENST00000427926.6
Benign
COSV99067208
0.003138280000rs36077768
193ENST00000427926.6BenignCOSV99067208rs36077768
COL1A1chr175018813450188134CTc.3223G>AGcc/Accp.A1075T0.996113Missense VariantMissense VariantMODERATEENST00000225964.10
Benign

rs1800215
113ENST00000225964.10Benignrs1800215
ELK4chr1205620109205620109CTc.937G>AGta/Atap.V313I0.48331Missense VariantMissense VariantMODERATEENST00000357992.9


0.000244833000rs34515238
31ENST00000357992.9rs34515238
EPHA3chr38921022489210224CGc.518C>GcCt/cGtp.P173R0.52851Missense VariantMissense VariantMODERATEENST00000336596.7



51ENST00000336596.7
ERCC5chr13102854340102854340GAc.433G>AGtt/Attp.V145I0.962141Missense VariantMissense VariantMODERATEENST00000652225.2
Benign/Likely_benign
COSV104673176
0.001582750000rs4987063
141ENST00000652225.2Benign/Likely_benignCOSV104673176rs4987063
ESR1chr6151808321151808321AGc.409A>GAgc/Ggcp.S137G0.976103Missense VariantMissense VariantMODERATEENST00000440973.5
Benign

0.000500829000rs185717042
103ENST00000440973.5Benignrs185717042
ETV5chr3186080022186080022GCc.445C>GCta/Gtap.L149V0.56241Missense VariantMissense VariantMODERATEENST00000306376.10
Benign

0.002721030000rs78506201
41ENST00000306376.10Benignrs78506201
CNV


Histology Information for Model: BCM-0132

Patient

PDX


Metastasis Information for Model: BCM-0132
 
Patient
PDX
Abdomen
Abdominal cavity
Adrenal Gland
Anterosuperior mediastinum
Ascites
Axillary Lymph Node
Bone
Brain
CTC
Chest
Chest wall
Contralateral Breast
Fallopian tubes
Head
Hilar Node
Hip
Kidney
Leg bone
Leptomeninges
Liver
Lung
Lymph Node
Mediastinum
Metastasis Pleura
Neck
None
Other
Ovary
Pancreas
Paratracheal adenopathy
Pericardium
Peritoneal cavity
Peritoneum
Pleura
Pleural cavity
Pleural effusion
Posterior cervical nodes
Pulmonary
Retrocrural Lymph Node
SVC node
Sacral Spine
Skin
Spine
Spleen
Thymus

Patient Treatment Information for Model: BCM-0132

Event IdTreatmentTreatment SettingAge at StartAge at EndDurationClinical ResponsePathologic ResponseReason Stopped
15Doxorubicin, CyclophosphamideNeoadjuvant58.9259.0340 daysPartial ResponseNot ApplicableTreatment Completed
20Carboplatin,PaclitaxelNeoadjuvant59.0959.3491 daysComplete ResponsePartial ResponseTreatment Completed
30DocetaxelAdjuvant59.4659.6362 daysNot ReportedNot ApplicableTreatment Completed
35Radiation Therapy (RT)Adjuvant59.7659.8429 daysNot ReportedNot ApplicableTreatment Completed
40CapecitabineAdjuvant59.9560.39161 daysStable DiseaseNot ApplicableTreatment Completed














Timeout
Your session is about to expire. Click 'Stay Connected' to continue the session.